Comprehensive online GMP training aligned with FDA, EMA, WHO, and ICH Q7 requirements — designed for the realities of Indian pharmaceutical manufacturing. Self-paced. 21 CFR Part 11 compliant certificates. Inspection-ready training records.
India is the world's largest supplier of generic medicines — supplying over 20% of global generic drug volumes and exporting to more than 200 countries. Indian pharmaceutical manufacturers are routinely inspected by the US FDA, the European Medicines Agency (EMA), the WHO, and the Central Drugs Standard Control Organisation (CDSCO).
For any Indian pharmaceutical professional working in manufacturing, quality assurance, regulatory affairs, or supply chain — GMP training is not optional. It is a regulatory requirement.
FDA Warning Letters and Import Alerts issued to Indian manufacturers are frequently related to data integrity failures, inadequate training records, and poor documentation practices — all of which structured GMP training directly addresses.
| Market | Regulatory Authority | GMP Framework |
|---|---|---|
| United States | US FDA | 21 CFR Parts 210 & 211, cGMP |
| European Union | EMA / EDQM | EudraLex Volume 4, EU GMP |
| Global / WHO Prequalification | WHO | WHO GMP guidelines |
| API Manufacturing | ICH | ICH Q7 |
| India (domestic) | CDSCO | Schedule M, aligned with WHO GMP |
All courses are self-paced, available online, and include 21 CFR Part 11 compliant certificates with verifiable IDs — accepted as documented training records during FDA, EMA, and WHO inspections of Indian facilities.
The most comprehensive GMP course available online — 19 modules covering the complete GMP framework aligned with FDA 21 CFR Parts 210 & 211, EMA EudraLex Volume 4, WHO GMP, and ICH Q7. Ideal for Indian API and formulation manufacturers preparing for multi-authority inspections.
For Indian manufacturers supplying the European market or seeking EU GMP certification. Covers EudraLex Volume 4 Parts I and II, the revised Annex 1 (sterile manufacturing, 2022), Annex 11 (computerised systems), Annex 15 (qualification and validation), and the Qualified Person (QP) requirement.
Enroll in EU GMP TrainingFor Indian pharmaceutical distributors, 3PLs, and export logistics teams. Covers WHO GDP guidelines and EU GDP guidelines — cold chain management, storage, transport, supplier qualification, and documentation requirements.
Enroll in GDP TrainingDesigned for Indian finished dosage form manufacturers exporting to the US market. Covers FDA 21 CFR Parts 210 & 211 cGMP requirements — personnel qualifications, buildings, equipment, production and process controls, laboratory controls, records, and distribution. Directly addresses USFDA inspection expectations for Indian facilities.
Enroll in cGMP TrainingGMP training is required for all personnel working in Indian pharmaceutical facilities that manufacture for regulated export markets, including the US, EU, and WHO. This covers production, quality, engineering, and supply chain roles at all levels.
Data integrity failures are the single most common reason Indian pharmaceutical manufacturers receive FDA Warning Letters and Import Alerts. The FDA requires that all records satisfy the ALCOA+ principles:
Our GMP training course includes a dedicated module on data integrity covering ALCOA+ principles, 21 CFR Part 11 compliance for electronic records, and EU GMP Annex 11 for computerised systems.
Our 21 CFR Part 11 compliant certificates provide auditable training records that FDA investigators accept during inspections of Indian facilities — covering PAIs, surveillance inspections, and for-cause inspections.
Indian pharmaceutical manufacturers preparing for FDA pre-approval inspections (PAIs) or surveillance inspections need to ensure training records are complete, current, and documented. Our training directly supports all four inspection readiness requirements.
All personnel have documented GMP training records with verifiable certificate IDs — acceptable to FDA investigators as evidence of training completion.
Training is role-specific and matched to each employee's responsibilities — demonstrating that training programs are structured, not generic.
Data integrity training is documented for all relevant personnel — the most common gap cited in FDA Warning Letters to Indian manufacturers.
Annual GMP refresher training is in place and documented — demonstrating an active, maintained training programme to inspectors.
Training your entire QA, production, or engineering team? We offer group enrollment for Indian pharmaceutical companies of all sizes — from small API manufacturers to large integrated pharma companies. Group quotes provided within 24 hours.
| Feature | GxP Trainings |
|---|---|
| FDA 21 CFR Parts 210 & 211 aligned | |
| EU GMP EudraLex Volume 4 aligned | |
| WHO GMP aligned | |
| ICH Q7 (API GMP) covered | |
| Data integrity / ALCOA+ training | |
| 21 CFR Part 11 compliant certificate | |
| Self-paced — study around shift schedules | |
| Instant certificate download | |
| Verifiable certificate ID | |
| Group / corporate enrollment |
Yes. The FDA does not mandate classroom training. What matters is that training is documented, assessed, and relevant to the employee's role. Our 21 CFR Part 11 compliant certificates are accepted as valid training records during FDA inspections of Indian facilities.
It depends on your export market. For the US: FDA 21 CFR Parts 210 & 211. For the EU: EudraLex Volume 4. For WHO prequalification: WHO GMP guidelines. For APIs: ICH Q7. Our GMP course covers all of these frameworks.
The most common reasons are data integrity failures, altered records, backdated entries, unsupported audit trail deletions, inadequate laboratory controls, and OOS investigation failures. All of these are covered in our GMP training course.
The full course (19 modules) takes approximately 8–10 hours at your own pace. You can study in sessions — ideal for personnel with shift-based schedules. You have 12 months from enrollment to complete it.
Yes. The certificate is 21 CFR Part 11 compliant with a unique verifiable ID. FDA investigators accept documented training records in this format during inspections of Indian manufacturing facilities.
Currently all courses are delivered in English — the language of FDA and EMA regulatory submissions and the standard for GMP documentation in regulated Indian facilities.
Yes. Contact us for group enrollment pricing for teams of 5 or more. We respond with a group quote within 24 hours.
Yes. Certificates are provided as downloadable PDFs and include all information required for your training matrix — course name, completion date, assessment score, and a unique verifiable certificate ID.
Equip your team with the GMP knowledge and documented training records required for FDA, EMA, and WHO inspection readiness.